Law ❯ Legal Firms ❯ Securities Law

Investor Advocacy

Legal Representation Class Action Representation

MoonLake Investors Get Deadline Reminder as Securities Suits Mount Over Sonelokimab Trial

The suits contend MoonLake overstated sonelokimab’s Nanobody advantages over BIMZELX after trial data coincided with a near-90% one-day share drop.